Showing 5141-5150 of 20470 results for "".
- Optimizing Outcomes in Borderline Resectable PDAC: A Multimodal Approachhttps://reachmd.com/news/borderline-resectable-pdac-multimodal-approach/2485200/In borderline resectable PDAC, individualized neoadjuvant therapy, advanced surgical techniques, and precise response asse
- Leveraging CD8 Activation Biomarkers for Surgical Decisions in HGSOChttps://reachmd.com/news/leveraging-cd8-activation-biomarkers-for-surgical-decisions-in-hgsoc/2485178/A pan-cohort study identifies CD8 lymphocyte activation biomarkers as a robust predictor of outcomes and treatment response in high-grade serous ovar
- Enhancing Embryo Quality in Advanced Maternal Age: The Role of Erzhi Tiangui Formulahttps://reachmd.com/news/embryo-quality-advanced-maternal-age-erzhi-tiangui/2485163/Use of the Erzhi Tiangui formula in patients undergoing IVF produced a statistically significant increase in the number of high-quality blastocysts and improved fertilization
- Navigating the Norovirus Surge: Essential Updates for Clinicianshttps://reachmd.com/news/navigating-the-norovirus-surge-essential-updates-for-clinicians/2485155/A notable norovirus surge is underway across parts of the country, producing higher caseloads in outpatient and institut
- Navigating the 2025 Microhematuria Guidelines: Key Updates for Clinicianshttps://reachmd.com/news/navigating-the-2025-microhematuria-guidelines-key-updates-for-clinicians/2485148/The American Urological Association, in collaboration with the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, has released a 2025 amendment to its
- FDA: Most PFAS in Cosmetics Lack Adequate Safety Datahttps://reachmd.com/news/fda-most-pfas-in-cosmetics-lack-adequate-safety-data/2485144/The U.S. Food and Drug Administration (FDA) announced that it has released its first congressionally mandated report under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), assessing the use and safety of perfluoroalkyl and polyfluoroalkyl substances (PF
- Discrimination, Language Gaps Undermine HS Care for Latine Adults: Analysishttps://reachmd.com/news/latine-patients-with-hs-face-barriers-in-pain-and-wound-care-study-finds-discrimination-language-gaps-undermine-hs-care-for-latine-adults/2485130/Latine patients with hidradenitis suppurativa (HS) continue to face barriers to care, according to a qualitative study published in JAMA Dermatology. Study researchers analyzed transcripts from semistructured interviews
- Rheologic Profiles Differ Markedly Between Cross-Linked and Non–Cross-Linked HA Fillers, Study Findshttps://reachmd.com/news/rheologic-profiles-differ-markedly-between-cross-linked-and-noncross-linked-ha-fillers-study-finds/2485091/Non–cross-linked and cross-linked hyaluronic acid (HA) dermal fillers demonstrate distinct rheologic behaviors under mechanical stress, with potential implications for product selection and injection depth, according to a comparative analysis of commercially available fillers published online in
- Unlocking Bone Health: The Promise of Exercise-Mimetic Proteinshttps://reachmd.com/news/bone-health-exercise-mimetic-proteins/2485134/Preclinical research suggests Piezo1, described as an exercise‑mimetic protein, may reproduce weight‑bearing benefits in mobility‑limited older adults. The investigators frame Piezo1 as a p
- Understanding Vitamin D's Role in Cancer Carehttps://reachmd.com/news/vitamin-d-cancer-outcomes/2485141/In a recent study, short-term, high‑dose vitamin D3 supplementation administered to vitamin D–insufficient patients with cancer— including a subset who received pembrolizumab —produced rapid shifts in peripheral immune-cell co